Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
-
- Carlos Alfaro
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Alvaro Teijeira
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Carmen Oñate
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Guiomar Pérez
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Miguel F. Sanmamed
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
-
- Maria Pilar Andueza
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
-
- Diego Alignani
- 4Cytometry Platform, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Sara Labiano
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Arantza Azpilikueta
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Alfonso Rodriguez-Paulete
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Saray Garasa
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Juan P. Fusco
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
-
- Angela Aznar
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Susana Inogés
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
-
- Maria De Pizzol
- 5Dompé Farmaceutici SpA, L'Aquila, Italy.
-
- Marcello Allegretti
- 5Dompé Farmaceutici SpA, L'Aquila, Italy.
-
- Jose Medina-Echeverz
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Pedro Berraondo
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
-
- Jose L. Perez-Gracia
- 2Department of Oncology, University Clinic of Navarra, Pamplona, Spain.
-
- Ignacio Melero
- 1Division of Gene Therapy and Hepatology, Centre for Applied Medical Research (CIMA), Pamplona, Spain.
書誌事項
- 公開日
- 2016-07-31
- DOI
-
- 10.1158/1078-0432.ccr-15-2463
- 公開者
- American Association for Cancer Research (AACR)
この論文をさがす
説明
<jats:title>Abstract</jats:title> <jats:p>Purpose: Myeloid-derived suppressor cells (MDSC) are considered an important T-cell immunosuppressive component in cancer-bearing hosts. The factors that attract these cells to the tumor microenvironment are poorly understood. IL8 (CXCL8) is a potent chemotactic factor for neutrophils and monocytes.</jats:p> <jats:p>Experimental Design: MDSC were characterized and sorted by multicolor flow cytometry on ficoll-gradient isolated blood leucokytes from healthy volunteers (n = 10) and advanced cancer patients (n = 28). In chemotaxis assays, sorted granulocytic and monocytic MDSC were tested in response to recombinant IL8, IL8 derived from cancer cell lines, and patient sera. Neutrophil extracellular traps (NETs) formation was assessed by confocal microscopy, fluorimetry, and time-lapse fluorescence confocal microscopy on short-term MDSC cultures.</jats:p> <jats:p>Results: IL8 chemoattracts both granulocytic (GrMDSC) and monocytic (MoMDSC) human MDSC. Monocytic but not granulocytic MDSC exerted a suppressor activity on the proliferation of autologous T cells isolated from the circulation of cancer patients. IL8 did not modify the T-cell suppressor activity of human MDSC. However, IL8 induced the formation of NETs in the GrMDSC subset.</jats:p> <jats:p>Conclusions: IL8 derived from tumors contributes to the chemotactic recruitment of MDSC and to their functional control. Clin Cancer Res; 22(15); 3924–36. ©2016 AACR.</jats:p>
収録刊行物
-
- Clinical Cancer Research
-
Clinical Cancer Research 22 (15), 3924-3936, 2016-07-31
American Association for Cancer Research (AACR)